Medtech Startups: Everlywell, AceAge, 4D Biomaterials, & more

Published on Dec 7, 2020


LSI's Medtech Startup Tracker is focused exclusively on covering the privately-held innovators changing the medical device landscape.  

EverlyWell – delivering lab-quality diagnostic testing directly to patients’ homes

EverlyWell is simplifying the process for receiving diagnostic testing by allowing patients to collect and send-off testing samples from home. Results are digitally delivered to patients within a few days. The company offers diagnostic tests for general wellness, men’s and women’s health, metabolic health, sexual health, and COVID-19. EverlyWell recently closed a Series D round worth $175M, bringing the total funds raised to-date by the company to $250M. Key strategics in the diagnostic testing market include Abbott, Illumina, and Roche.

Start a Free Trial to Medtech Startup Tracker Today

AceAge is taking on medication adherence challenges with Karie

Karie is a benchtop home health appliance that helps elderly patients living alone organize, schedule, deliver and monitor their medication. In addition to automating medication regimens, Karie also alerts family members and healthcare providers when patients miss a dose. In December 2020, AceAge raised approximately $3.9M in a Series A round. AdhereTech, Cardinal Health, and McKesson are some of the key strategics in this market.

4D Biomaterials is developing proprietary biomaterials for 3D printing and medical devices

The company’s biomaterials will address the limitations of currently available biomaterials. They are being developed to be non-toxic upon degradation, promote tissue regeneration, be biocompatible, and have mechanical properties suited to host tissue. The technology could optimize outcomes in several clinical applications, including cancer treatment, degenerative spinal conditions, and reconstructive surgery. 4D Biomaterials recently acquired its first injection of capital with a grant from Innovate UK and a pre-seed round of funding from SFC Capital. 

Endomag raises $20.1M in Series D round

The funds will be utilized to scale market reach, employee headcount, and product offerings. Endomag’s Sentimag localization system uses non-invasive magnetic sensing to pinpoint breast cancer during surgery and determine if cancer has spread. As of this latest round of funding, the company has raised approximately $38.8M. GE Healthcare, Hologic, and Mammotome are some of the key players in the strategic landscape.

Knok Healthcare – an easy to integrate telemedicine platform

Knok Healthcare has developed Panacea, a software-as-a-service (SaaS) platform that can be easily implemented in hospitals and other healthcare organizations. Panacea allows healthcare organization conduct video calls with patients, schedule appointments, and evaluate patients independently with an AI chat bot. The company has raised approximately $2.4M to-date. Major players in the telemedicine market include MDLive & Teladoc Health.

Atreon Orthopedics is using nanofibers for soft tissue repair

The FDA cleared Rotium Bioresorbable Wick is a nanofiber scaffold that supports cellular ingrowth and proliferation of healthy tendon in rotator cuff repair surgeries. Atreon Orthopedics is a subsidiary of ParaGen Technologies, a company focused on the development of tissue regeneration solutions. Key strategics in this market include Orthofix, Stryker, and Zimmer-Biomet.

Learn about the hottest venture funded startups developing innovative medical technologies using Life Science Intelligence’s Medtech Startup Tracker.

Topics: Medtech, Startup, Strategics, Insider, Medtech Innovation Weekly Update

Join us at the next LSI Emerging Medtech Summit

LSI's global events attract top innovators, active investors, and deal-making strategics.


Our Clients